Stockreport

Tectonic Therapeutic: Interesting CV Disease Drug Developer [Seeking Alpha]

Tectonic Therapeutic, Inc.  (TECX) 
PDF Investing Group Leader Follow Summary Tectonic Therapeutic's lead candidate TX45 showed positive phase 1 results for Group 2 Pulmonary Hypertension, driving the s [Read more]